[Efficacy of acupuncture-moxibustion on peripheral facial paralysis at different time points: a Meta-analysis]

To systematically evaluate the efficacy and safety differences between acupuncture-moxibustion at acute stage and non-acute stage for peripheral facial paralysis.

The clinical trials regarding acupuncture- moxibustion for peripheral facial paralysis published before May 31st 2019 were searched in databases of CNKI, WF, VIP, SinoMed, PubMed, Cochrane Library and Google Scholar. The information of included studies was extracted and the quality was assessed by two independent researchers. The Meta-analysis was performed by using RevMan 5.3 software.

A total of 11 trials were included, involving 1741 patients. The Meta-analysis results showed that: (1) the curative rate of acupuncture-moxibustion at acute stage was higher than that at non-acute stage (OR=2.45, 95%CI: 1.91-3.14, Z=7.06, P<0.01); (2) the average curative time of acupuncture-moxibustion at acute stage were shorter than that of non-acute stage (WMD=5.26, 95%CI: 3.44, 7.08, Z=5.67, P<0.01); (3) the incidence rate of sequelae in 6-month follow up of acupuncture-moxibustion at acute stage were lower than that of non-acute stage (OR=2.71, 95%CI: 1.26, 5.84, Z=2.56, P<0.05); (4) one study reported that there were no adverse reactions during treatment in both treatment group and control group.

Based on current evidence, the efficacy of acupuncture-moxibustion at acute stage is superior to non-acute stage, which could promote the recovery of the disease and shorten the course of treatment, and reduce the occurrence of sequelae. More high-quality, large-sample randomized controlled trials are needed for further verification.